Current Drug Targets
Title:Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease
Volume: 22 Issue: 14
Author(s): Md. Sahab Uddin*, Umme Tabassum Arobi Katha and Ghulam Md. Ashraf*
Affiliation:
- Department of Pharmacy, Southeast University, Dhaka,Bangladesh
- Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah,Saudi Arabia
Export Options
About this article
Cite this article as:
Uddin Sahab Md. *, Katha Tabassum Arobi Umme and Ashraf Md. Ghulam *, Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease, Current Drug Targets 2021; 22 (14) . https://dx.doi.org/10.2174/1389450122666210309105326
DOI https://dx.doi.org/10.2174/1389450122666210309105326 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Connections Between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis
Current Alzheimer Research Application of Proteomics to the Discovery of Cancer Biomarkers
Current Cancer Therapy Reviews The Need for Calcium Channels in Cell Proliferation
Recent Patents on Anti-Cancer Drug Discovery Separation of Ginseng Active Ingredients and their Roles in Cancer Metastasis Supplementary Therapy
Current Drug Metabolism Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery The Physiological Characteristics and Transcytosis Mechanisms of the Blood-Brain Barrier (BBB)
Current Pharmaceutical Biotechnology Possible Neuroprotective Strategies in ALS
Current Neuropharmacology Anticancer Agents Derived from Natural Products
Mini-Reviews in Medicinal Chemistry Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease
Current Drug Targets The Role of Adenosine in Alzheimers Disease
Current Neuropharmacology Apoptosis and Autophagy Induction As Mechanism of Cancer Prevention by Naturally Occurring Dietary Agents
Current Drug Targets Treating Schizophrenia: Novel Targets for the Cholinergic System
CNS & Neurological Disorders - Drug Targets Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design Interaction of Proteins with Lipid Rafts Through Glycolipid-Binding Domains:Biochemical Background and Potential Therapeutic Applications
Current Medicinal Chemistry Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy
Current Pharmaceutical Design Cellular Toxicity of Mesoporous Silica Nanoparticle in SHSY5Y and BMMNCs Cell
Pharmaceutical Nanotechnology New Trends in Fiber-Optic Chemical and Biological Sensors
Current Analytical Chemistry The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design